Glucose, insulin and myocardial ischaemia
Authors:
- René ChioléroRCRené Chioléro
- Greet Van Den BergheGBGreet Van Den Berghe
- Jean-Charles PreiserJPJean-Charles Preiser
- 1 March 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Clinical Nutrition and Metabolic Care
- Vol. 9 (2) , 131-139
Abstract
The importance of glucose metabolism and insulin therapy during myocardial ischaemia is increasingly being investigated. Insulin is used to achieve a tight glucose control or as part of glucose-insulin-potassium therapy. We have reviewed (1) the physiological and physiopathological consequences of hyperglycaemia focusing on potential machanisms of myocardial ischaemia, (2) the effects of insulin on vascular tone, on the release of free fatty acids, on inflammatory pathways, on the switch of energy source and on apoptosis, and (3) clinical data reporting the effects of intensive insulin therapy and glucose-insulin-potassium solutions during myocardial ischaemia and ischaemic heart failure. In addition to its known toxic cellular effects, hyperglycaemia increases the activity of inducible nitric oxide synthase and promotes inflammation. Conversely insulin exerts anti-inflammatory and anti-apoptotic effects. Glucose-insulin-potassium solutions could improve survival after acute myocardial infarction or after surgery, according to recent meta-analyses, but confirmation of these data is eagerly awaited. Hyperglycaemia is toxic, while insulin is beneficial during acute myocardial ischaemia. Some recent evidence confirms a substantial benefit of insulin administered either alone to achieve a tight glucose control or as a component of glucose-insulin-potassium therapy. Further research is needed to confirm that tendency and to define the threshold of tight glucose control.Keywords
This publication has 67 references indexed in Scilit:
- Insulin infusion in acute illnessJournal of Clinical Investigation, 2005
- Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complicationsPharmacological Research, 2005
- ST-segment elevation resolution and outcome in patients treated with primary angioplasty and glucose-insulin-potassium infusionAmerican Heart Journal, 2005
- Glucose-insulin-potassium and reperfusion in acute myocardial infarction: Rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2)American Heart Journal, 2005
- Effect of glucose-insulin-potassium infusion on plasma free fatty acid concentrations in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarctionThe American Journal of Cardiology, 2004
- Effect of an Intensive Glucose Management Protocol on the Mortality of Critically Ill Adult PatientsMayo Clinic Proceedings, 2004
- A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapyAmerican Heart Journal, 2004
- Glucose and insulin changes in infants and children undergoing hypothermic open-heart surgeryThe American Journal of Cardiology, 1983
- Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusionAmerican Heart Journal, 1976
- Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarctionThe American Journal of Cardiology, 1962